INTRODUCTION: Malignant ventricular arrhythmias (MVA) are often the main cause of sudden cardiac death (SCD), especially in patients with pre-existing coronary artery disease (CAD). The identification of factors associated with SCD in this clinical setting is important and might help physicians in identifying this high risk group of patients. We evaluated the association between 12-lead ECG ventricular repolarization parameters and the induction of MVA on the electrophysiological study (EPS). METHODS AND RESULTS: 177 patients [mean age 65±10.1yo, 83.6% male, mean LV ejection fraction (LVEF) 37.5±13.6%] were analyzed. For each 10ms increment in the QT interval, an increase of 7% in MVA inducibility was observed. The QT cut-off point of 452 ms had and accuracy of 0.611 for predicting MVA (p=0.011). Male gender (OR=4.18, p=0.012), LVEF < 35% (OR=2.32, p=0.013), amiodarone use (OR=2.01, p=0.038) and prolonged QT (OR=1.07, p=0.023) were independent factors associated with MVA. QT > 452ms in patients with ventricular dysfunction was associated with significant increased risk of MVA (OR=5.44, p=0.0004). In patients with LVEF [?] 35%, QT dispersion (QTd) was significantly higher in those with inducible MVA. QTd > 20ms had an accuracy of 0.638 in predicting MVA, with 81.3% negative predictive value (95% CI 63-92.1%). CONCLUSION: QT interval was an independent factor associated with MVA in patients with CAD. The combination of ventricular dysfunction and prolonged QT interval was associated with a 5-fold increase of MVA induction. Male gender, amiodarone use and decreased LVEF were also associated with increased risk of inducibility of MVA on the EPS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.